125 jobs are to be created over the next three years at Oranmore-based Neurent Medical, a rapidly growing innovator in ear, nose, and throat (ENT ) healthcare solutions.
The announcement was made at the official opening of its new, state-of-the-art, manufacturing facility at Westlink Commercial Park in Oranmore, Co. Galway.
Attended by Minister Hildegarde Naughton TD and Jenny Melia, CEO (Designate ), Enterprise Ireland, the new facility marks a significant milestone for Neurent Medical and will create 125 new highly skilled jobs by the end of 2028. It will serve as the central hub for the production of the Company’s innovative NEUROMARK® system, a novel, and minimally invasive, treatment option designed to target the underlying drivers of Chronic Rhinitis.
The new facility represents a major investment in Ireland’s thriving MedTech ecosystem in Galway. The new jobs will range across key functions in Engineering, Quality Control, Operations, Supply Chain Management, and Sales and Marketing. In-house manufacturing of NEUROMARK will enable Neurent Medical to deepen its regional footprint in Galway and strengthen its control over product quality, innovation, and international distribution.
Originating from the Enterprise Ireland-supported BioInnovate Ireland Programme, Neurent Medical has grown from concept to commercialisation within a decade, emerging as one of Ireland’s MedTech success stories. Since its inception, the company has leveraged Galway’s world-class innovation ecosystem to scale its team, secure FDA regulatory clearances, and attract top international clinical collaborators.
Hildegarde Naughton, TD, Minister of State at the Department of Children, Disability and Equality, said that Galway is known as a major player in Medical Technology, being home to 8 of the world’s top 10 MedTech companies.
“This announcement is further evidence of that and, as a native myself, I am particularly proud to see 125 new highly skilled jobs being created by a company based in Oranmore.
“It is also highly notable that this is an Irish company, supported by Enterprise Ireland, and selling into the US market. I have no doubt, given their impressive growth to date, that this will be but one of many major achievements for the company,” she added.
Brian Shields, CEO of Neurent Medical, said that they were proud to scale operations in Galway, where the MedTech ecosystem continues to thrive.
“Our new Westlink facility gives us the manufacturing capacity to meet growing demand for NEUROMARK, while creating high skilled employment opportunities and contributing to economic vitality in the west of Ireland. As an Irish-founded company, we’re excited to manufacture our product locally with the exceptional skills available and deliver Irish-engineered MedTech innovation to the world,” HE SAID.
Neurent Medical’s latest expansion reflects their continued progress and follows recent FDA 510(k ) clearance for its next-generation NEUROMARK System, which paves the way for broader commercialisation in the United States.
The Company continues to collaborate with regional enterprise partners, including Enterprise Ireland and local academic institutions, to build a strong pipeline of talent and drive the next generation of MedTech growth from the west of Ireland.
Jenny Melia, Executive Director and incoming CEO at Enterprise Ireland congratulated Neurent Medical “This announcement of new jobs based here in Oranmore shows that Ireland is leading in research and development within the medical device space, ” she said.
“Neurent Medical has experienced impressive growth in a short period of time beginning its journey through the BioInnovate Ireland Programme here in Galway with further support awarded through EI’s Commercialisation fund programme and through the Disruptive Technologies Innovation Fund administered by Enterprise Ireland for the development of the NEUROMARK technology.
“Supporting Irish companies with the ambition to scale globally is a key priority for Enterprise Ireland and we will continue to work closely with Brian and the team at Neurent Medical to optimise their full international growth potential, creating and sustaining jobs here in the Galway region,” Ms Melia added.
